Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RF (radiofrequency) arrhythmia ablation proves safe in infants:

This article was originally published in Clinica

Executive Summary

A US study has quashed concerns that using radiofrequency catheter ablation (RFCA) as a treatment for tachycardia may not be as effective and safe in infants as it is in older paediatric patients. Andrew Blaufox, of the Medical University of South Carolina in Charleston and his team found no statistical difference between infants and older patients in RFCA's effectiveness in treating arrhythmias, although the trend in success favoured the older patients, 90% versus 87.6% for infants, the team reports in Circulation (December 4).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074362

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel